Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: A report from the french society of pediatric oncology

Journal of Clinical Oncology

Volumn 27, Issue 30, 2009, Pages 5056-5061

  Brugières, Laurence ^a   Pacquement, Helene ^a   Le Deley, Marie Cecile ^a   Leverger, Guy ^a   Lutz, Patrick ^a   Paillard, Catherine ^a   Baruchel, Andre ^a   Frappaz, Didier ^a   Nelken, Brigitte ^a   Lamant, Laurence ^a   Patte, Catherine ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CARMUSTINE; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; METHOTREXATE; PREDNISOLONE; PREDNISONE; PROCARBAZINE; STEROID; VINBLASTINE; VINCRISTINE; VINDESINE;

ARTICLE; BLOOD TOXICITY; CANCER RELAPSE; CANCER SURGERY; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; EVENT FREE SURVIVAL; FRANCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LARGE CELL LYMPHOMA; MEDICAL SOCIETY; OVERALL SURVIVAL; PEDIATRICS; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REMISSION; SALVAGE THERAPY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; WHOLE BODY RADIATION;

ANTINEOPLASTIC AGENTS; CHILD; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINBLASTINE;

EID: 77649160262     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.20.1764     Document Type: Article

References (33)

1. Morris SW, Kirstein MN, Valentine MB, et al: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281-1284, 1994
2. Brugières L, Deley MC, Pacquement H, et al: CD30(+) anaplastic large-cell lymphoma in children: Analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood 92:3591-3598, 1998
3. Reiter A, Schrappe M, Tiemann M, et al: Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol 12:899-908, 1994
4. Seidemann K, Tiemann M, Schrappe M, et al: Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood 97:3699-3706, 2001
5. Williams DM, Hobson R, Imeson J, et al: Anaplastic large cell lymphoma in childhood: Analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens. Br J Haematol 117:812-820, 2002
6. Laver JH, Kraveka JM, Hutchison RE, et al: Advanced-stage large-cell lymphoma in children and adolescents: Results of a randomized trial incorporating intermediate-dose methotrexate and highdose cytarabine in the maintenance phase of the APO regimen: A Pediatric Oncology Group phase III trial. J Clin Oncol 23:541-547, 2005
7. Massimino M, Gasparini M, Giardini R: Ki-1 (CD30) anaplastic large-cell lymphoma in children. Ann Oncol 6:915-920, 1995
8. Mori T, Kiyokawa N, Shimada H, et al: Anaplastic large cell lymphoma in Japanese children: Retrospective analysis of 34 patients diagnosed at the National Research Institute for Child Health and Development. Br J Haematol 121:94-96, 2003
9. Rosolen A, Pillon M, Garaventa A, et al: Anaplastic large cell lymphoma treated with a leukemialike therapy: Report of the Italian Association of Pediatric Hematology and Oncology (AIEOP) LNH-92 protocol. Cancer 104:2133-2140, 2005
10. Sandlund JT, Pui CH, Santana VM, et al: Clinical features and treatment outcome for children with CD30+ large-cell non-Hodgkin's lymphoma. J Clin Oncol 12:895-898, 1994
11. Bordon V, De Paepe P, Dhooge C, et al: Successful treatment with allogeneic bone marrow transplantation of an early relapse of ALK-positive anaplastic large cell lymphoma. Haematologica 90: ECR19, 2005
12. Brugières L, Quartier P, Le Deley MC, et al: Relapses of childhood anaplastic large-cell lymphoma: Treatment results in a series of 41 children-a report from the French Society of Pediatric Oncology. Ann Oncol 11:53-58, 2000
13. Cesaro S, Pillon M, Visintin G, et al: Unrelated bone marrow transplantation for high-risk anaplastic large cell lymphoma in pediatric patients: A single center case series. Eur J Haematol 75:22-26, 2005
14. Chen AI, McMillan A, Negrin RS, et al: Longterm results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: The Stanford experience. Biol Blood Marrow Transplant 14:741-747, 2008
15. Deconinck E, Lamy T, Foussard C, et al: Autologous stem cell transplantation for anaplastic large-cell lymphomas: Results of a prospective trial. Br J Haematol 109:736-742, 2000
16. Loiseau HA, Hartmann O, Valteau D, et al: High-dose chemotherapy containing busulfan followed by bone marrow transplantation in 24 children with refractory or relapsed non-Hodgkin's lymphoma. Bone Marrow Transplant 8:465-472, 1991
17. Mori T, Takimoto T, Katano N, et al: Recurrent childhood anaplastic large cell lymphoma: A retrospective analysis of registered cases in Japan. Br J Haematol 132:594-597, 2006
18. Woessmann W, Peters C, Lenhard M, et al: Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents-a Berlin-Frankfurt-Münster group report. Br J Haematol 133: 176-182, 2006
19. Jaffe ES: Anaplastic large cell lymphoma: The shifting sands of diagnostic hematopathology. Mod Pathol 14:219-228, 2001
20. Rothman KJ: Estimation of confidence limits for the cumulative probability of survival in life table analysis. J Chronic Dis 31:557-560, 1978
21. Schemper M, Smith TL: A note on quantifying follow-up in studies of failure time. Control Clin Trials 17:343-346, 1996
22. Brugières L, Caillaud JM, Patte C, et al: Malignant histiocytosis: Therapeutic results in 27 children treated with a single polychemotherapy regimen. Med Pediatr Oncol 17:193-196, 1989
23. Brugières L, Le Deley M, Rosolen A, et al: Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: Results of a randomized trial of the EICNHL group. J Clin Oncol 27:897-903, 2009
24. Caballero MD, Rubio V, Rifon J, et al: BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: Analysis of efficacy, toxicity and prognostic factors. Bone Marrow Transplant 20:451-458, 1997
25. Gadner H, Grois N, Arico M, et al: A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr 138:728-734, 2001
26. Little R, Wittes RE, Longo DL, et al: Vinblastine for recurrent Hodgkin's disease following autologous bone marrow transplant. J Clin Oncol 16:584-588, 1998
27. Jelliffe A: Vinblastine in the treatment of Hodgkin's disease. Br J Cancer 23:44-48, 1969
28. Klener P, Donner L, Ort J: Use of vinblastine for maintenance therapy in malignant lymphoma. Neoplasma 21:323-329, 1974
29. Stutzman L, Ezdinli EZ, Stutzman MA: Vinblastine sulfate vs cyclophosphamide in the therapy for lymphoma. JAMA 195:173-178, 1966
30. Hill JM, Loeb E: Treatment of leukemia, lymphoma, and other malignant neoplasms with Vinblastine. Cancer Chemother Rep 15:41-61, 1961
31. Muto A, Nakagawa A, Shimomura Y, et al: Antineoplastic agents for pediatric anaplastic large cell lymphoma: Vinblastine is the most effective in vitro. Leuk Lymphoma 46:1489-1496, 2005
32. Pulford K, Falini B, Banham AH, et al: Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma. Blood 96:1605-1607, 2000
33. Coluccia AM, Gunby RH, Tartari CJ, et al: Anaplastic lymphoma kinase and its signalling molecules as novel targets in lymphoma therapy. Expert Opin Ther Targets 9:515-532, 2005